Company Factsheet
Alliance Pharmaceuticals, a speciality pharmaceutical company, is listed on the London Stock Exchange (APH) and is part of the FTSE AIM All Share and Health Care index.
| IFRS | IFRS | IFRS | IFRS | IFRS | ||
| Year (Period) ended | 31 Dec 2005* | 31 Dec 2006 | 31 Dec 2007 | 31 Dec 2008 | 31 Dec 2009 | |
| Revenue | £m | 12.3 | 17.3 | 18.2 | 21.8 | 31.2 |
| Operating profit before exceptional items | £m | 2.0 | 2.6 | 3.6 | 6.4 | 11.2 |
| Exceptional operating items | £m | 0.2 | - | (3.6) | - | (2.8) |
| Operating profit after exceptional items | £m | 2.2 | 2.6 | - | 6.4 | 8.4 |
| Profit before tax before exceptional items | £m | 0.5 | 0.5 | 0.4 | 2.4 | 8.5 |
| Profit/(loss) before tax after exceptional items | £m | 0.7 | 0.5 | (3.2) | 2.4 | 5.7 |
| Intangible assets | £m | 29.7 | 39.5 | 39.2 | 40.0 | 44.9 |
| Tangible assets | £m | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 |
| Current assets | £m | 5.8 | 8.3 | 7.0 | 8.7 | 11.7 |
| Current liabilities | £m | 6.1 | 11.0 | 9.8 | 11.1 | 11.4 |
| Equity | £m | 7.5 | 10.4 | 6.7 | 8.8 | 16.6 |
| Year (Period) ended | 31 Dec 2005* | 31 Dec 2006 | 31 Dec 2007 | 31 Dec 2008 | 31 Dec 2009 | |
| Average shares in issue | m | 147.4 | 156.7 | 162.1 | 162.1 | 173.2 |
| Shares in issue at period end | m | 147.4 | 162.1 | 162.1 | 162.1 | 193.3 |
| Year (Period) ended | 31 Dec 2005* | 31 Dec 2006 | 31 Dec 2007 | 31 Dec 2008 | 31 Dec 2009 | |
| Earnings per share - basic | (p) | 0.45 | 0.32 | (1.98) | 1.55 | 2.37 |
| Earnings per share - adjusted basic | (p) | 0.30 | 0.32 | 0.23 | 1.17 | 3.55 |
Financial Calendar
| Previous Key Dates | |
| End of Year | 31 Dec 2009 |
| Trading Update | Early January 2010 |
| Preliminary Announcement | 24 March 2010 |
| Annual Report | April 2010 |
| AGM | 27 May 2010 |
| Trading Update | Early July 2010 |
| Half-year Results Announcement | 8 September 2010 |
Delivered by global3digital
© Alliance Pharmaceuticals.All Rights Reserved